Nexo Therapeutics
PrivateLast Round
Series B
Mar 27, 2026
Total Funding Raised
$60M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nexo Therapeutics is a biotechnology company that develops small-molecule therapies for oncology patients using a covalent ligand discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nexo Therapeutics Comparables
Compare Nexo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Totus Medicines | 89% | |
| Covant Therapeutics | 87% | |
| BridGene Biosciences | 87% |
Nexo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 27, 2026 | ||||
| Series A | Jul 26, 2023 |
Nexo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Series A |
| Cormorant Asset Management | Series A |
| Versant Ventures | Series A |
| Cormorant Asset Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 41% MoM, reaching 2.2K.
- Apr 17, 2026
Monthly visitors grew 64% MoM.
Nexo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nexo Therapeutics's valuation, stock price, and market status.
Is Nexo Therapeutics a public or private company?
Nexo Therapeutics is a private company.
What is the current stock price of Nexo Therapeutics?
Nexo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Nexo Therapeutics worth (valuation)?
Valuation information for Nexo Therapeutics is not publicly available.
Can I buy Nexo Therapeutics stock?
Nexo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nexo Therapeutics's last funding round?
Nexo Therapeutics's most recent funding round was Series B on March 27, 2026.
Who are the main investors in Nexo Therapeutics?
Key investors in Nexo Therapeutics include Versant Ventures.
Will Nexo Therapeutics IPO soon?
No public IPO plans have been announced for Nexo Therapeutics.
How can I track Nexo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nexo Therapeutics's secondary market activity and sign up for updates.